Patents by Inventor Wolfgang Wiehl

Wolfgang Wiehl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LYSOBACTIN FOR USE IN THE TREATMENT OF BOVINE MASTITIS
    Publication number: 20230125394
    Abstract: The present invention relates to lysobactin for use in the treatment of bovine mastitis.
    Type: Application
    Filed: June 6, 2022
    Publication date: April 27, 2023
    Inventors: Guido SCHIFFER, Stefan FALKER, Gert DAUBE, Kristine FRAATZ, Wolfgang WIEHL, Johannes KOEBBERLING
  • Topically administrable formulation for the control and prevention of animal parasites
    Patent number: 11344532
    Abstract: The invention relates to novel liquid formulations suitable for topical administration to animals, which formulations comprise a fluorine-containing antiparasitic active compound and also triethyl phosphate, and to their use for the control and prevention of animal parasites.
    Type: Grant
    Filed: September 3, 2018
    Date of Patent: May 31, 2022
    Assignee: Bayer Animal Health GmbH
    Inventors: Wolfgang Wiehl, Petra Ohage-Spitzlei, Franziska Schmidt
  • COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS
    Publication number: 20220000969
    Abstract: The present invention relates to the combination of lysobactin with an aminoglycoside antibiotic for use in the treatment of diseases caused by Gram-positive and Gram-negative bacteria in non-human animals. The invention proved to be particularly useful relating to the treatment of mastitis in non-human animals. Particularly bovine mastitis can be well addressed by the present invention.
    Type: Application
    Filed: September 3, 2021
    Publication date: January 6, 2022
    Inventors: Guido SCHIFFER, Stefan FALKER, Gert DAUBE, Wolfgang WIEHL, Johannes KOEBBERLING
  • TOPICALLY ADMINISTRABLE FORMULATION FOR THE CONTROL AND PREVENTION OF ANIMAL PARASITES
    Publication number: 20210059986
    Abstract: The invention relates to novel liquid formulations suitable for topical administration to animals, which formulations comprise a fluorine-containing antiparasitic active compound and also triethyl phosphate, and to their use for the control and prevention of animal parasites.
    Type: Application
    Filed: September 3, 2018
    Publication date: March 4, 2021
    Inventors: Wolfgang WIEHL, Petra OHAGE-SPITZLEI, Franziska SCHMIDT
  • COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS
    Publication number: 20200230204
    Abstract: The present invention relates to the combination of lysobactin with an aminoglycoside antibiotic for use in the treatment of diseases caused by Gram-positive and Gram-negative bacteria in non-human animals. The invention proved to be particularly useful relating to the treatment of mastitis in non-human animals. Particularly bovine mastitis can be well addressed by the present invention.
    Type: Application
    Filed: February 14, 2018
    Publication date: July 23, 2020
    Applicant: Bayer Animal Health GmbH
    Inventors: Guido SCHIFFER, Stefan FÄLKER, Gert DAUBE, Wolfgang WIEHL, Johannes KÖBBERLING
  • Pharmaceutical compositions and treatment of mastitis
    Patent number: 10265330
    Abstract: The present invention relates to a pharmaceutical composition and methods of treating and/or preventing mastitis in non-human mammals. More particularly, the present invention relates to the treatment of mastitis in cows. The pharmaceutical composition comprises a mixture of a phosphonic acid and at least one antimicrobial.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: April 23, 2019
    Assignee: BAYER ANIMAL HEALTH GMBH
    Inventors: Robrecht Froyman, Heinz-Georg Wetzstein, Kristine Fraatz, Wolfgang Wiehl
  • LYSOBACTIN FOR USE IN THE TREATMENT OF BOVINE MASTITIS
    Publication number: 20180346518
    Abstract: The present invention relates to lysobactin for use in the treatment of bovine mastitis.
    Type: Application
    Filed: August 16, 2016
    Publication date: December 6, 2018
    Inventors: Guido Schiffer, Stefan Falker, Gert Daube, Kristine Fraatz, Wolfgang Wiehl, Johannes Kobberling
  • Dosing dispenser
    Patent number: 9452105
    Abstract: The invention relates to a dosing dispenser having a dosing piston, for dosing formulations of a drug or nutritional supplement in the form of a free-flowing bulk material having a particle diameter in the range of 100-1000 ?m.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 27, 2016
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Uwe Müller, Sölen Siemers, Wolfgang Wiehl, Sabine Göttke
  • PHARMACEUTICAL COMPOSITIONS AND TREATMENT OF MASTITIS
    Publication number: 20150164926
    Abstract: The present invention relates to a pharmaceutical composition and methods of treating and/or preventing mastitis in non-human mammals. More particularly, the present invention relates to the treatment of mastitis in cows. The pharmaceutical composition comprises a mixture of a phosphonic acid and at least one antimicrobial.
    Type: Application
    Filed: June 25, 2013
    Publication date: June 18, 2015
    Inventors: Robrecht Froyman, Heinz-Georg Wetzstein, Kristine Fraatz, Wolfgang Wiehl
  • DOSING DISPENSER
    Publication number: 20150041491
    Abstract: The invention relates to a dosing dispenser having a dosing piston, for dosing formulations of a drug or nutritional supplement in the form of a free-flowing bulk material having a particle diameter in the range of 100-1000 ?m.
    Type: Application
    Filed: March 15, 2013
    Publication date: February 12, 2015
    Applicant: Bayer IntellectualProperty GmbH
    Inventors: Uwe Müller, Sölen Siemers, Wolfgang Wiehl, Sabine Göttke
  • SUSPENSION FORMULATION FOR CARBON ADSORBENTS
    Publication number: 20110021641
    Abstract: The invention relates to an aqueous suspension formulation comprising a coarsely particulate carbon adsorbent which is suitable for binding and eliminating harmful substances from the gastrointestinal tract, and a water-soluble or water-dispersible structure-forming agent and a humectant.
    Type: Application
    Filed: February 28, 2009
    Publication date: January 27, 2011
    Inventors: Olaf Behrend, Iris Heep, Nikolaus Kowollik, Dirk Mertin, Petra Ohage-Spitzlei, Bernard Schmidt, Wolfgang Wiehl
  • Effervescent preparation of a basic medicinally active substance
    Publication number: 20070048375
    Abstract: The present invention relates to an effervescent preparation comprising an effervescent composition, at least one basic medicinally active substance and, where appropriate, one or more further active ingredients, characterized in that alkalization of the urine and thus increased accumulation of the basic medicinally active substance is avoided, to medicaments comprising this effervescent preparation, to processes for the production thereof and to the use thereof.
    Type: Application
    Filed: June 16, 2006
    Publication date: March 1, 2007
    Inventors: Wolfgang Wiehl, Ralf Bullesbach, Dieter Rehn, Irene Loose
  • Analgesic combination
    Patent number: 6929805
    Abstract: The present invention relates to medicinal preparations which can be administered orally and contain a fixed combination of at least one locally acting analgesic with a rapid onset of action and at least one systemically acting analgesic with a sustained action.
    Type: Grant
    Filed: April 2, 1998
    Date of Patent: August 16, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Neuser, Monika Fierus, Wolfgang Wiehl
  • ANALGESIC COMBINATION
    Publication number: 20010002999
    Abstract: The present invention relates to medicinal preparations which can be administered orally and contain a fixed combination of at least one locally acting analgesic with a rapid onset of action and at least one systemically acting analgesic with a sustained action.
    Type: Application
    Filed: October 8, 1999
    Publication date: June 7, 2001
    Inventors: DIETER NEUSER, MONIKA FIERUS, WOLFGANG WIEHL